Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9529005
Modulating bacterial MAM polypeptides in pathogenic disease
granted patentUS 9527917
Nucleic acid encoding anti-OX40 antibodies
granted patentUS 9527884
Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein
granted patentUS 9526824
Nanochanneled device and related methods
granted patentUS 9523079
Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
granted patentUS 9522241
Controlled release nanoparticulate matter delivery system
granted patentUS 9517270
Lipocationic polymers and uses thereof
granted patentUS 9517230
Small molecule RNase inhibitors and methods of use
granted patentUS 9512212
Bispecific antibody fragments for neurological disease proteins and methods of use
granted patentUS 9512204
Humanized pertussis antibodies and uses thereof
granted patentUS 9512401
B and T lymphocyte attenuator marker for use in adoptive T-cell therapy
granted patentUS 9511152
Multicolored pH-activatable fluorescence nanoplatform
granted patentUS 9506040
Prevascularized constructs for implantation to provide blood perfusion
granted patentUS 9504754
Curcuminoid complexes with enhanced stability, solubility and/or bioavailability
granted patentUS 9504745
Compositions and methods for cancer treatment using targeted carbon nanotubes
granted patentUS 9504742
Compositions for stimulation of mammalian innate immune resistance to pathogens
granted patentUS 9504701
Methods for treating viral infections using hydrogen sulfide donors
granted patentUS 9504658
Stabilized HME composition with small drug particles
granted patentUS 9502711
Fabrication of biscrolled fiber using carbon nanotube sheet
granted patentUS 9499608
Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS pene
granted patentUS 9499595
Development of influenza A antivirals
granted patentUS 9499588
Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereo
granted patentUS 9498533
Drug delivery compositions and methods
granted patentUS 9492523
Broadly protective Shigella vaccine based on type III secretion apparatus proteins
granted